Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Jonathan Kay MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Kay, Jonathan

Item TypeName
Academic Article Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.
Academic Article E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
Academic Article Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Academic Article The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I.
Academic Article Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160.
Academic Article Evolution of treatment for rheumatoid arthritis.
Academic Article Biosimilars: a regulatory perspective from America.
Academic Article Assessment of control of rheumatoid arthritis disease activity.
Academic Article The advent of biosimilar therapies in rheumatology--"O brave new world".
Academic Article ACR/EULAR 2010 rheumatoid arthritis classification criteria.
Academic Article The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Academic Article Biosimilars to treat inflammatory arthritis: the challenge of proving identity.
Concept Antirheumatic Agents
Academic Article Methotrexate: the gold standard without standardisation.
Academic Article Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
Academic Article Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study.
Academic Article Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Academic Article Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).
Academic Article Quality indicators in rheumatoid arthritis: results from the METEOR database.
Academic Article The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016.
Academic Article The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
Academic Article Biosimilars in rheumatology: current perspectives and lessons learnt.

Search Criteria
  • Antirheumatic Agents